Beijing Science Sun Pharmaceutical Co Ltd (300485) — Long-term Investment Intensity
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Long-term Investment Intensity of 13.0% as of September 2019. Long-term investments of CN¥359.33 Million represent 13.0% of total assets of CN¥2.77 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 300485 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Beijing Science Sun Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 13.0%, reflecting long-term investments of CN¥359.33 Million against total assets of CN¥2.77 Billion CNY. Explore 300485 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Beijing Science Sun Pharmaceutical Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Beijing Science Sun Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 300485 market cap overview.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 9.5% | CN¥262.03 Million | CN¥2.76 Billion | ▲ +0.1 pp |
| 2017 | 9.4% | CN¥230.66 Million | CN¥2.45 Billion | ▼ -0.1 pp |
| 2016 | 9.5% | CN¥210.09 Million | CN¥2.22 Billion | ▲ +4.1 pp |
| 2015 | 5.4% | CN¥105.00 Million | CN¥1.94 Billion | — |